Table 3.
Comparison of the prevalence of ocular abnormalities in RP patients with previous studies
| First author | Coun-try | Subjects/ Eyes (No.) | Macular abnormalities (Eyes / %) | Cataract (Eyes/%) | Glaucoma (Eyes/%) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Total | CME | ERM | VMT | MH | |||||
| Hajali [6] | USA | 124/248 | 115/46.4 | ||||||
| Testa [1] | Italy | 581/1161 | 524/45.1 | 237/20.4 | 181/15.6 | 58/5.0 | 23/2.0 | ||
| Fujiwar-a [19] | Japan | 117/206 | 73/35.4 | 73/35.4 | |||||
| Liew [5] | UK | 169/338 | 172/50.9 | 77/22.8 | |||||
| Testa [13] | Italy | 134/268 | 126/47.0 | 42/15.7 | 51/19.0 | 38/14.2 | 8/3.0 | ||
| Lee [20] | Korea | 365/365 | 175/47.9 | ||||||
| Onakpo-ya OH [2] | Nigeria | 96/192 | 70/36.5 | 38/20 | 22/11.5 | ||||
| Our study | China | 1065/2127 | 829/59.7 | 255/18.4 | 709/51.1 | 33/2.4 | 32/2.3 | 917/43.1 | 35/1.6 |
CME Cystoid macular edema, ERM Epiretinal membrane, VMT Vitreomacular traction syndrome, MH Macular hole